Alia Shakiba
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Alia Shakiba has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Maryam Noroozian
Cognitive Neurology, Dementia and Neuropsychiatry Research Center, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications - Ali Khaleghi
Psychiatry and Psychology Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication - Ali Talebi
Department of Clinical Pharmacy Faculty of Pharmacy Tehran University of Medical Sciences Tehran Iran
1 shared publication - Alireza Kargar
Iran National Drug and Poison Information Center (NDPIC), Ministry of Health Tehran Iran
1 shared publication - Ameneh Ahmadi
Psychiatry and Psychology Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication Azadeh Sadat Zendehbad
Department of Geriatric Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 15 July 2025
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 83 (12) , 001-009
Clinical validation study of the Persian version of the Rapid Eye Movement Sleep Behavior Disorder Screening Questionnaire (RBDSQ-PER)
Rapid eye movement (REM) sleep behavior disorder (RBD) is marked by abnormal behaviors during REM sleep and is associated with neurodegenerative diseases, such as Parkinson's disease. Early diagnosis is critical for managing these associations effectively. To validate the Persian version of the RBD Screening Questionnaire (RBDSQ-PER) for Persian-speaking patients. The study involved 171 participants from sleep centers associated with the Tehran University of Medical Sciences, including Parkinson's disease patients with RBD, individuals with obstructive sleep apnea, and healthy controls. The RBDSQ was translated into Persian following established linguistic validation protocols. Reliability and diagnostic utility were measured with Cronbach's alpha to determine internal consistency and the intraclass correlation coefficient. The RBDSQ-PER demonstrated a Cronbach's alpha and intraclass correlation coefficient of 0.847, indicating strong internal consistency. The analysis of the receiver operating characteristic curve established a cut-off score of 5.5, differentiating individuals with and without RBD with 100% sensitivity and 93% specificity. The RBDSQ-PER is a reliable tool for screening in Persian-speaking populations, enhancing initial sleep assessments and guiding further diagnostic evaluations. Future research should consider broader patient groups to extend the questionnaire's applicability.
- 15 July 2025
- Published by Georg Thieme Verlag KG in Arquivos de Neuro-Psiquiatria
- Vol. 83 (12) , 001-009
Open AccessClinical validation study of the Persian version of the Rapid Eye Movement Sleep Behavior Disorder Screening Questionnaire (RBDSQ-PER)
Rapid eye movement (REM) sleep behavior disorder (RBD) is marked by abnormal behaviors during REM sleep and is associated with neurodegenerative diseases, such as Parkinson's disease. Early diagnosis is critical for managing these associations effectively. To validate the Persian version of the RBD Screening Questionnaire (RBDSQ-PER) for Persian-speaking patients. The study involved 171 participants from sleep centers associated with the Tehran University of Medical Sciences, including Parkinson's disease patients with RBD, individuals with obstructive sleep apnea, and healthy controls. The RBDSQ was translated into Persian following established linguistic validation protocols. Reliability and diagnostic utility were measured with Cronbach's alpha to determine internal consistency and the intraclass correlation coefficient. The RBDSQ-PER demonstrated a Cronbach's alpha and intraclass correlation coefficient of 0.847, indicating strong internal consistency. The analysis of the receiver operating characteristic curve established a cut-off score of 5.5, differentiating individuals with and without RBD with 100% sensitivity and 93% specificity. The RBDSQ-PER is a reliable tool for screening in Persian-speaking populations, enhancing initial sleep assessments and guiding further diagnostic evaluations. Future research should consider broader patient groups to extend the questionnaire's applicability.
- Open Access
- 1 May 2024
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 15 (3) , 273-286
Effect of Controlling the Cardiovascular Risk Factors on the Cognitive Decline Prevention in the Elderly: A Systematic Review
With the increasing proportion of the elderly population, neurodegenerative diseases such as dementia are becoming more prevalent worldwide. Vascular risk factors are considered significant targets for cognitive decline prevention. We reviewed the effect of cardiovascular risk factors on cognitive decline prevention in the elderly to evaluate the quantity and quality of evidence in managing the elderly population with cognitive decline. Data analysis was available from 25 studies that explored the effects of controlling cardiovascular risk factors on the risk of cognitive impairment. These risk factors include diabetes mellitus, high blood pressure, high cholesterol levels, and exercise and physical activity. The most positive evidence was found for exercise and physical activity. On the other hand, diabetes mellitus and cholesterol modifications showed no positive impact on cognitive function. Studies on hypertension control were incongruous. There is a need for large-sample, robust randomized clinical trials to provide sufficient evidence for the modification of various cardiovascular risk factors in preventing cognitive decline.
- 1 May 2024
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 15 (3) , 273-286
Open AccessEffect of Controlling the Cardiovascular Risk Factors on the Cognitive Decline Prevention in the Elderly: A Systematic Review
With the increasing proportion of the elderly population, neurodegenerative diseases such as dementia are becoming more prevalent worldwide. Vascular risk factors are considered significant targets for cognitive decline prevention. We reviewed the effect of cardiovascular risk factors on cognitive decline prevention in the elderly to evaluate the quantity and quality of evidence in managing the elderly population with cognitive decline. Data analysis was available from 25 studies that explored the effects of controlling cardiovascular risk factors on the risk of cognitive impairment. These risk factors include diabetes mellitus, high blood pressure, high cholesterol levels, and exercise and physical activity. The most positive evidence was found for exercise and physical activity. On the other hand, diabetes mellitus and cholesterol modifications showed no positive impact on cognitive function. Studies on hypertension control were incongruous. There is a need for large-sample, robust randomized clinical trials to provide sufficient evidence for the modification of various cardiovascular risk factors in preventing cognitive decline.
- Open Access
- 30 May 2020
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 11 (2) , 147-162
Drug Interactions of Psychiatric and COVID-19 Medications
Introduction: Coronavirus disease 2019 (COVID-19) has become a pandemic with 1771514 cases identified in the world and 70029 cases in Iran until April 12, 2020. The co-prescription of psychotropics with COVID-19 medication is not uncommon. Healthcare providers should be familiar with many Potential Drug-Drug Interactions (DDIs) between COVID-19 therapeutic agents and ...
- 30 May 2020
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 11 (2) , 147-162
Open AccessDrug Interactions of Psychiatric and COVID-19 Medications
Introduction: Coronavirus disease 2019 (COVID-19) has become a pandemic with 1771514 cases identified in the world and 70029 cases in Iran until April 12, 2020. The co-prescription of psychotropics with COVID-19 medication is not uncommon. Healthcare providers should be familiar with many Potential Drug-Drug Interactions (DDIs) between COVID-19 therapeutic agents and ...
- 10 March 2020
- Published by Springer Nature in Social Indicators Research
- Vol. 150 (2) , 375-391
Application of Different Techniques of Factor Analysis to Develop Neighborhood Social Capital Rating Scale
- 10 March 2020
- Published by Springer Nature in Social Indicators Research
- Vol. 150 (2) , 375-391
Application of Different Techniques of Factor Analysis to Develop Neighborhood Social Capital Rating Scale
- 2 January 2020
- Published by Taylor & Francis in Applied Neuropsychology: Adult
- Vol. 29 (1) , 77-82
Validation of Iranian Smell Identification Test for screening of mild cognitive impairment and Alzheimer’s disease
Background: According to the World Alzheimer Report 2019, an estimated 50 million people worldwide are living with dementia. The smell test is a method for early detection of Alzheimer’s disease (AD) as an inexpensive, simple, and noninvasive screening tool. This study aimed to evaluate the accuracy of the Iran Smell Identification Test (Iran-SIT) in discriminating patients with AD, with mild cognitive impairment (MCI), and the healthy subjects. Methods: In this study, 42 patients with AD, 33 with MCI, and 32 healthy controls were recruited from the referral Memory Clinic of Tehran University of Medical Sciences. The olfactory function was examined with six odors through Iran-SIT. Results: We found a significant difference among the olfactory function in subjects with normal cognitive status, that of those with MCI and those with AD (p < 0.001). The cutoff point for the diagnosis of AD was (sensitivity and specificity were, respectively, 85.7 and 90.8%), and (Sensitivity and specificity were, respectively, 93.9 and 100%) for MCI. Conclusion: These results suggest that Iran-SIT is a valid biomarker and practical screening tool, with simple, inexpensive, and readily available for use in combination with neuropsychological tools and neuroimaging for early detection of AD.
- 2 January 2020
- Published by Taylor & Francis in Applied Neuropsychology: Adult
- Vol. 29 (1) , 77-82
Validation of Iranian Smell Identification Test for screening of mild cognitive impairment and Alzheimer’s disease
Background: According to the World Alzheimer Report 2019, an estimated 50 million people worldwide are living with dementia. The smell test is a method for early detection of Alzheimer’s disease (AD) as an inexpensive, simple, and noninvasive screening tool. This study aimed to evaluate the accuracy of the Iran Smell Identification Test (Iran-SIT) in discriminating patients with AD, with mild cognitive impairment (MCI), and the healthy subjects. Methods: In this study, 42 patients with AD, 33 with MCI, and 32 healthy controls were recruited from the referral Memory Clinic of Tehran University of Medical Sciences. The olfactory function was examined with six odors through Iran-SIT. Results: We found a significant difference among the olfactory function in subjects with normal cognitive status, that of those with MCI and those with AD (p < 0.001). The cutoff point for the diagnosis of AD was (sensitivity and specificity were, respectively, 85.7 and 90.8%), and (Sensitivity and specificity were, respectively, 93.9 and 100%) for MCI. Conclusion: These results suggest that Iran-SIT is a valid biomarker and practical screening tool, with simple, inexpensive, and readily available for use in combination with neuropsychological tools and neuroimaging for early detection of AD.
- Open Access
- 28 August 2014
- Published by Elsevier in International Psychogeriatrics
- Vol. 26 (12) , 2051-2060
The impact of illiteracy on the assessment of cognition and dementia: a critical issue in the developing countries
- 28 August 2014
- Published by Elsevier in International Psychogeriatrics
- Vol. 26 (12) , 2051-2060
Open AccessThe impact of illiteracy on the assessment of cognition and dementia: a critical issue in the developing countries